Genetic polymorphism of tumor necrosis factor promoter region and susceptibility to develop Hodgkin lymphoma in a Mexican population

References

• Gutiérrez M. Enfermedad de Hodgkin. Gac Méd Mex 2002;138: 307–309.
   Google Scholar
• Globocan, 2008 [Internet]. 2012. Available from: http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=484
   Google Scholar
• Reyes CC, Wu X, Spitz M, et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 2008;9:777–785.
   PubMed Web of Science ®Google Scholar
• Thorley DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Eng J Med 2004;350: 1328–1337.
   PubMed Web of Science ®Google Scholar
• Campbell KS, Hasegawa J. Natural killer cell biology: an update and future directions. J Allergy Clin Immunol 2013;132:1065–1068.
   Web of Science ®Google Scholar
• Poppema S. Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology 2005;2005:231–238.
   Google Scholar
• Naylor MS, Stamp GW, Foulkes WD, et al. Tumour necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 1992;91:2194–2206.
   Web of Science ®Google Scholar
• Anaya J. Descripción molecular de TNF. Reumatología 2003;19: 112–120.
   Google Scholar
• Goldin LR, Pfeiffer RM, Gridley G, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 2004;100: 1902–1908.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick A, Bidwell J, van den Brule A, et al. TNFα polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 2004;92:675–679.
   PubMed Web of Science ®Google Scholar
• Kohaar I, Thakur N, Salhan S, et al. TNFalpha-308 G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 2007;29:249–256.
   PubMed Web of Science ®Google Scholar
• Ivansson EL, Magnusson JJ, Magnusson PK, et al. MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2. Genes Immun 2008;9:613–623.
   PubMed Web of Science ®Google Scholar
• Zuñiga J, Vargas G, Hernández G, et al. Tumor necrosis factor-α promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2000;12:363–366.
   Google Scholar
• Jiménez S, Velázquez R, Ramírez J, et al. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol 2009;70:251–256.
   PubMed Web of Science ®Google Scholar
• Deshpande A, Nolan JP, White PS, et al. TNFα promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 2005;15:969–976.
   Web of Science ®Google Scholar
• Calhoun ES, McGovern RM, Janney CA, et al. Host genetic polymorphism analysis in cervical cancer. Clin Chem 2002;48: 1218–1224.
   PubMed Web of Science ®Google Scholar
• Jang WH, Yang YI, Yea SS, et al. The -238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 2001;166:41–46.
   PubMed Web of Science ®Google Scholar
• Zhou P, Qiang G, Wang JZ, et al. The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis. PLoS One 2011;6:1–5.
   Web of Science ®Google Scholar
• Tirado L, Mohar A. Epidemiología de las enfermedades Hemato-Oncológicas. Cancerología 2007;2:109–120.
   Google Scholar
• Xu B, Niu X, Wang Z, et al. IL-6 -174G.C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Mol Biol Rep 2011;34:2589–2596.
   Web of Science ®Google Scholar
• Nieves ME, Partida O, Alegre P, et al. Characterization of single-nucleotide polymorphisms in the tumor necrosis factor α promoter region and in lymphotoxin α in squamous intraepithelial lesions, precursors of cervical cancer. Transl Oncol 2011;4:336–344.
   PubMed Web of Science ®Google Scholar
• Knight J, Udalova I, Hill AV, et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999;22:145–150.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Giachelia M, Di Febo A, et al. Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma. Ann Oncol 2007;18:1376–1381.
   PubMed Web of Science ®Google Scholar
• Cozen W, Gill PS, Ingles SA, et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood 2004;103:3216–322
   PubMed Web of Science ®Google Scholar
• Morales G, Falfán R, García RA, et al. Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case–control study. BMC Infect Dis 2012;12: 299–308.
   PubMed Web of Science ®Google Scholar
• Kei-Hang C, Kathleen B, Nai-Chieh Y, et al. Common variations in the genes encoding C-reactive protein, tumor necrosis factor, and interleukin-6, and the risk of clinical diabetes in the women's health initiative observational study. Clin Chem 2011;57:317–325.
   PubMed Web of Science ®Google Scholar
• Schürks M, Kurth T, Buring JE, et al. A candidate gene association study of 77 polymorphisms in migraine. J Pain 2009;10:759–766.
   PubMed Web of Science ®Google Scholar
• Badano I, Schurr TG, Stietz SM, et al. TNF promoter SNP variation in Amerindians and white-admixed women from Misiones, Argentina. Int J Immunogenet 2012;40:216–221.
   PubMed Web of Science ®Google Scholar
• Emonts M, Veenhoven RH, Wiertsema SP, et al. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics 2007;120:814–823.
   PubMed Web of Science ®Google Scholar
• Howell W, Turner S, Collins A, et al. Influence of TNFα and LTα single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population. Eur J Immunogenet 2002;29:17–23.
   PubMedGoogle Scholar
• Pappa S, Hatzistilianou M, Kouvatsi A, et al. Tumour necrosis factor gene polymorphisms and migraine in Greek children. Arch Med Sci 2010;6:430–437.
   Web of Science ®Google Scholar
• Villar L, Espin o M, Cavanillas ML, et al. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis. Clin Immunol 2010;137:51–59.
   PubMed Web of Science ®Google Scholar
• Kothari N, Bogra J, Abbas H, et al. Tumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shock. Cytokine 2013;61:676–681.
   PubMed Web of Science ®Google Scholar
• Valente FP, Tan CR, Temple SE, et al. The evolution and diversity of TNF block haplotypes in European, Asian and Australian aboriginal populations. Genes Immun 2009;10:607–615.
   PubMed Web of Science ®Google Scholar
• Clark T, Diakite M, Aurburn S, Tumor necrosis factor and lymphotoxin-α polymorphisms and severe malaria in African populations. J infect Dis 2009;199:569–575.
   PubMed Web of Science ®Google Scholar
• Zhen ZZ, Nyholt D, Lien LE, et al. Genetic variation in tumor necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample. Hum Reprod 2007;22:2389–2397.
   PubMed Web of Science ®Google Scholar
• Cognitive genomics [Internet]. BGI Institute Beijing, China. 2013. Available from: https://www.cog-genomics.org/software/stats.
   Google Scholar